HELP     Sign In
Search

Relevance to Autism

A maternally-inherited frameshift variant in the DGKI gene was observed in two of three ASD-affected siblings from a multiplex family from the iHART cohort (Ruzzo et al., 2019), while de novo missense variants that were predicted to be damaging were identified in this gene in two ASD probands (Satterstrom et al., 2020; More et al., 2023). This gene has previously been reported to have a possible association with susceptibility to dyslexia in Finnish and German populations (Matsson et al., 2011).

Molecular Function

This gene is a member of the type IV diacylglycerol kinase subfamily. Diacylglycerol kinases regulate the intracellular concentration of diacylglycerol through its phosphorylation, producing phosphatidic acid. The specific role of the enzyme encoded by this gene is undetermined, however, it may play a crucial role in the production of phosphatidic acid in the retina or in recessive forms of retinal degeneration.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
ASD
Positive Association
Dyslexia
Support
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN1389R001 
 frameshift_variant 
 c.2285_2286insGT 
 p.Cys762TrpfsTer11 
 Familial 
 Maternal 
 Multiplex 
 GEN1389R002 
 missense_variant 
 c.3016C>T 
 p.Leu1006%3D 
 De novo 
  
  
 GEN1389R003 
 missense_variant 
 c.224G>T 
 p.Gly75Val 
 De novo 
  
 Multiplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
7
Deletion
 2
 
7
Duplication
 1
 
7
Deletion
 1
 
7
Duplication
 1
 
7
Deletion-Duplication
 17
 
7
Deletion
 1
 
7
Deletion
 2
 
7
Duplication
 1
 

No Animal Model Data Available

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.